At a glance
ClinicalIndex Comparison RecordN/ACompleted· 8 enrolled / 8 target
Drug / intervention
Shortcutdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Prospective, Multicenter, Non-Randomized, Single-Arm, Open-Label Continued Access Study of the ShortCut™ Device (The ShortCut™ CAS).
In Brief
A clinical study evaluating Shortcut for Valve-in-valve Procedures and 2 related conditions. Completed, enrolled 8 participants across 4 sites.
Signals
Enrollment appears stalled
Detailed Summary
A Prospective, Multicenter, Non-Randomized, Single-Arm, Open-Label Continued Access Study of the ShortCut™ device (The ShortCut™ CAS).
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
202420252026
First PostedJan 2024
Enrollment StartJul 2024
Primary CompletionMay 2025
TodayJul 2026
First PostedJan 18, 2024
Enrollment StartJul 3, 2024
Primary CompletionMay 12, 2025
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 2.5 years ago
Arms & Interventions
Shortcutexperimental
Splitting bioprosthetic aortic valve leaflets
Device: Shortcut
Interventions
Shortcutdevice
Splitting bioprosthetic aortic valve leaflets